|
2024
|
Invention
|
Method for treating moderate and severe psoriasis using recombinant anti-il-23p19 antibody. The p... |
|
|
Invention
|
Cysteine engineered antibody and immunoconjugate. Provided is an antibody engineered with a react... |
|
|
Invention
|
Methods of treating age-related macular degeneration and diabetic macular edema. Disclosed herein... |
|
|
Invention
|
Method for treating plaque psoriasis wherein subject previously receiving biologic therapy for pl... |
|
|
Invention
|
Anti-ox40l antibody and use thereof. A novel antibody and antibody fragment that specifically bin... |
|
|
Invention
|
Use of recombinant anti-interleukin 23p19 subunit antibody in treating inflammatory bowel disease... |
|
|
Invention
|
Preparation and use of anti-gprc5d/bcma/cd3 trispecific antibody. A trispecific antigen binding p... |
|
|
Invention
|
Anti-pvrig antibody and use thereof. The present invention relates to an antibody that specifical... |
|
|
Invention
|
Modified antibodies, antibody fragments thereof, and antibody-drug conjugates. Provided are modif... |
|
|
Invention
|
Method for treating psoriasis with recombinant interleukin 23p19 antibody. The present invention ... |
|
|
Invention
|
Anti-cd40l antibody and use thereof in treatment of human autoimmune diseases. An antibody and an... |
|
|
Invention
|
Antibody-drug conjugates of camptothecin derivatives and uses thereof. Disclosed are compounds of... |
|
|
G/S
|
Pharmaceutical preparations; gases for medical purposes;
medicines for human purposes; drugs for... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of gastrointestinal disorders; gases for medical pu... |
|
|
Invention
|
Pharmaceutical preparation containing anti-vegfa and anti-vegfc bispecific binding protein. Provi... |
|
2023
|
Invention
|
Trispecific fusion protein and use thereof. The present invention relates to a multispecific fusi... |
|
|
Invention
|
Preparation containing bispecific binding molecule binding to vegf and ang2 and use thereof. A pr... |
|
|
Invention
|
Mutant promoting homologous pairing of heavy and light chains of multispecific antibody. The pres... |
|
|
Invention
|
Treatment method using mazdutide. The present invention belongs to the field of medicine, and spe... |
|
2022
|
Invention
|
Antibody-drug conjugate targeting claudin18.2. An antibody-drug conjugate (ADC) targeting Claudin... |
|
|
Invention
|
Antibody binding to bcma and use thereof.
Provided are an antibody having an improved affinity f... |
|
|
Invention
|
Antibody binding to bcma and use thereof. Provided are an antibody having an improved affinity fo... |
|
|
Invention
|
Pharmaceutical combination comprising anti-pd-1 antibody and anti-vegf-a antibody and method for ... |
|
|
Invention
|
Interleukin-2 mutant and fusion protein thereof. Disclosed are a new interleukin-2 (IL-2) mutant ... |
|
|
Invention
|
Pharmaceutical composition of anti-pd-1 antibody and chemotherapy agent and method for using same... |
|
|
Invention
|
Anti-vegf a and -vegf c bispecific antibody and use thereof. A single-domain antibody polypeptide... |
|
|
Invention
|
Anti-vegf a and vegf c bispecific antibodies and use thereof. A single-domain antibody polypeptid... |
|
|
Invention
|
Anti-cd79bxcd3 bispecific antibody and use thereof.
The present invention relates to an antibody... |
|
|
Invention
|
Anti-cd79bxcd3 bispecific antibody and use thereof. Provided are an antibody that specifically bi... |
|
|
Invention
|
Anti-cd79b×cd3 bispecific antibody and use thereof. Provided are an antibody that specifically bi... |
|
|
Invention
|
Antibody against claudin 18.2 and use thereof. Provided are a novel antibody and antibody fragmen... |
|
|
Invention
|
Use of mazdutide.
The present invention discloses use of mazdutide, more particularly, use of a ... |
|
|
Invention
|
Use of mazdutide. Disclosed is the use of mazdutide. Specifically disclosed is the use of a compo... |
|
|
Invention
|
Bispecific binding molecule binding to vegf and ang2 and use thereof.
The present invention rela... |
|
|
Invention
|
Bispecific binding molecule binding to vegf and ang2 and use thereof. Provided are an antibody ag... |
|
|
Invention
|
Fc mutant with altered binding to fc receptor.
The present invention relates to a modified immun... |
|
|
Invention
|
Oxm3 storage agent, oxm3 formulation and preparation method.
Disclosed are an OXM3 storage agent... |
|
|
Invention
|
Anti-gprc5dxbcmaxcd3 trispecific antibody and use thereof.
The present invention relates to a tr... |
|
|
Invention
|
Anti-tnfr2 antibody and use thereof.
The present invention relates to an anti-TNFR2 antibody, a ... |
|
|
Invention
|
Single-domain antibody against cd16a and use thereof.
The present invention relates to an isolat... |
|
2021
|
Invention
|
Protein containing heterodimer antibody fc, and preparation method therefor.
The present inventi... |
|
|
Invention
|
Claudin18.2 chimeric antigen receptor and use thereof.
The present invention generally relates t... |
|
|
Invention
|
Interleukin-21 mutant and use thereof.
The present invention relates to a novel interleukin-21 (... |
|
|
G/S
|
Capital investment; financing services; providing financial information; providing insurance info... |
|
|
Invention
|
Monoclonal antibody for coronavirus spike protein, and use thereof.
Provided are an antibody or ... |
|
|
Invention
|
Pd-l1/lag-3 bispecific antibody formulation and preparation method therefor and use thereof.
The... |
|
|
Invention
|
Anti-ang-2 antibody and its usage.
The present invention relates to novel antibodies and antibod... |
|
|
Invention
|
Anti-cd73 antibody and uses thereof.
The present invention relates to novel antibodies or antige... |
|
|
Invention
|
Formulation comprising anti-il-23p19 antibody, method for preparing same and use thereof.
The pr... |
|
|
Invention
|
Recombinant fully human anti-tigit monoclonal antibody formulation, method for preparing same and... |
|
2020
|
Invention
|
Use of fusion protein in treatment of age-related macular degeneration.
The present invention re... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; vaccines; pharmaceutical drugs for the t... |
|
|
G/S
|
Medicines for human purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; v... |
|
|
G/S
|
Medicines for human purposes for the treatment of tumors, ophthalmology diseases, cardiovascular ... |
|
|
G/S
|
Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment... |
|
|
G/S
|
Medicines for human purposes; biochemical medicines; liquid
medicines; blood products; pharmaceu... |
|
|
Invention
|
Novel kras g12c protein inhibitor, preparation method therefor, and use thereof.
The present inv... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of gastrointestinal disorders; vaccines, namely hum... |
|
|
G/S
|
Pharmaceutical preparations; vaccines; drugs for medical
purposes; biological preparations for m... |
|
|
G/S
|
Medicines for human purposes; biochemical medicines; liquid
medicines; pharmaceutical preparatio... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; vaccines; drugs for the treatment of can... |
|
|
G/S
|
Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular dise... |
|
2019
|
G/S
|
Biochemical medicines for the treatment of cancer; dietetic substances for medical use consisting... |
|
|
G/S
|
Biochemical medicines for the treatment of cancer; dietetic foods adapted for medical use; biolog... |
|
|
G/S
|
Biochemical medicines; dietetic substances adapted for
medical use; biological preparations for ... |
|
|
G/S
|
Pharmaceutical preparations; medicines for human purposes;
drugs for medical purposes; biologica... |
|
2018
|
G/S
|
medicines for human purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; v... |
|
|
G/S
|
Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular dis... |
|
|
G/S
|
Medicines for human purposes; pharmaceutical preparations;
vaccines; drugs for medical purposes;... |
|
|
G/S
|
Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparat... |
|
2017
|
G/S
|
Medicines for human purposes, namely medicines for the treatment of cancers, ophthalmologic disea... |
